Abderrahim Oussalah1,2,3, Julien Levy1,2, Pierre Filhine-Trésarrieu1,2,3, Fares Namour1,2,3, Jean-Louis Guéant4,2,3. 1. Department of Molecular Medicine and Personalized Therapeutics. 2. Department of Biochemistry, Molecular Biology, Nutrition, and Metabolism, and. 3. INSERM, Unité 954, Nutrition, Genetics, and Environmental Risk Exposure, Faculty of Medicine of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France. 4. Department of Molecular Medicine and Personalized Therapeutics, jean-louis.gueant@univ-lorraine.fr.
Abstract
Background: Vitamin B-12 (cobalamin) deficiency may produce severe neurologic and hematologic manifestations. Approximately 20-25% of circulating cobalamin binds to transcobalamin 2 (TCN2), which is referred to as active vitamin B-12. The G allele of the TCN2 c.776G>C (rs1801198) polymorphism has been associated with a lower plasma concentration of holotranscobalamin. However, genotype association studies on rs1801198 have led to conflicting results regarding its influence on one-carbon metabolism (OCM) markers or its association with pathologic conditions.Objective: We assessed the association of rs1801198 genotypes with OCM marker concentrations and primary risks of congenital abnormalities, cancer, and Alzheimer disease.Design: We conducted a systematic review of the literature that was published from January 1966 to February 2017 and included all studies that assessed the association between rs1801198 and OCM markers or a pathologic condition. Results: Thirty-four studies met the inclusion criteria. Subjects with the rs1801198 GG genotype had significantly lower concentrations of holotranscobalamin [standardized mean difference (SMD): -0.445 (95% CI: -0.673, -0.217; P < 0.001); I2 = 48.16% (95% CI: 0.00%, 78.10%; P = 0.07)] and higher concentrations of homocysteine (European descent only) [SMD: 0.070 (95% CI: 0.020, 0.120; P = 0.01); I2 = 0.00% (95% CI: 0.00%, 49.59%; P = 0.73)] than did subjects with the rs1801198 CC genotype. The meta-analysis on the association between rs1801198 and methylmalonic acid (MMA) lacked statistical power. No significant difference was observed regarding cobalamin, folate, and red blood cell folate. No significant association was observed between rs1801198 and primary risks of congenital abnormalities, cancer, or Alzheimer disease.Conclusions: Meta-analysis results indicate an influence of rs1801198 on holotranscobalamin and homocysteine concentrations in European-descent subjects. In addition, well-designed and -powered studies should be conducted for assessing the association between rs1801198 and MMA and clinical manifestations that are linked to a decreased availability of cobalamin. This review was registered at www.crd.york.ac.uk/prospero as CRD42017058504.
Background: Vitamin B-12 (cobalamin) deficiency may produce severe neurologic and hematologic manifestations. Approximately 20-25% of circulating cobalamin binds to transcobalamin 2 (TCN2), which is referred to as active vitamin B-12. The G allele of the TCN2 c.776G>C (rs1801198) polymorphism has been associated with a lower plasma concentration of holotranscobalamin. However, genotype association studies on rs1801198 have led to conflicting results regarding its influence on one-carbon metabolism (OCM) markers or its association with pathologic conditions.Objective: We assessed the association of rs1801198 genotypes with OCM marker concentrations and primary risks of congenital abnormalities, cancer, and Alzheimer disease.Design: We conducted a systematic review of the literature that was published from January 1966 to February 2017 and included all studies that assessed the association between rs1801198 and OCM markers or a pathologic condition. Results: Thirty-four studies met the inclusion criteria. Subjects with the rs1801198 GG genotype had significantly lower concentrations of holotranscobalamin [standardized mean difference (SMD): -0.445 (95% CI: -0.673, -0.217; P < 0.001); I2 = 48.16% (95% CI: 0.00%, 78.10%; P = 0.07)] and higher concentrations of homocysteine (European descent only) [SMD: 0.070 (95% CI: 0.020, 0.120; P = 0.01); I2 = 0.00% (95% CI: 0.00%, 49.59%; P = 0.73)] than did subjects with the rs1801198 CC genotype. The meta-analysis on the association between rs1801198 and methylmalonic acid (MMA) lacked statistical power. No significant difference was observed regarding cobalamin, folate, and red blood cell folate. No significant association was observed between rs1801198 and primary risks of congenital abnormalities, cancer, or Alzheimer disease.Conclusions: Meta-analysis results indicate an influence of rs1801198 on holotranscobalamin and homocysteine concentrations in European-descent subjects. In addition, well-designed and -powered studies should be conducted for assessing the association between rs1801198 and MMA and clinical manifestations that are linked to a decreased availability of cobalamin. This review was registered at www.crd.york.ac.uk/prospero as CRD42017058504.
Authors: James L Mills; Charlotte M Druschel; Faith Pangilinan; Kenneth Pass; Christopher Cox; Rebecca R Seltzer; Mary R Conley; Lawrence C Brody Journal: Am J Med Genet A Date: 2005-07-01 Impact factor: 2.802
Authors: Ting-Yuan David Cheng; Mmadili N Ilozumba; Yesilda Balavarca; Marian L Neuhouser; Joshua W Miller; Shirley A A Beresford; Yingye Zheng; Xiaoling Song; David J Duggan; Adetunji T Toriola; Lynn B Bailey; Ralph Green; Marie A Caudill; Cornelia M Ulrich Journal: J Nutr Date: 2022-04-01 Impact factor: 4.798
Authors: Bit Na Kwon; Noo Ri Lee; Hyung Jun Kim; Yun Dan Kang; Jong Soo Kim; Jin Wan Park; Han Jun Jin Journal: Genes Genomics Date: 2021-05-24 Impact factor: 1.839
Authors: Tanja Jankovic-Karasoulos; Denise L Furness; Shalem Y Leemaqz; Gustaaf A Dekker; Luke E Grzeskowiak; Jessica A Grieger; Prabha H Andraweera; Dylan McCullough; Dale McAninch; Lesley M McCowan; Tina Bianco-Miotto; Claire T Roberts Journal: Matern Child Nutr Date: 2020-07-28 Impact factor: 3.092
Authors: Rhodi E Bulloch; Clare R Wall; Lesley M E McCowan; Rennae S Taylor; Claire T Roberts; John M D Thompson Journal: Nutrients Date: 2020-06-04 Impact factor: 5.717